𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

✍ Scribed by Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani; Enrique de Ramon Garrido; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; Renato Alberto Sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
130 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of low-dose versus high-dose cy
✍ Joel A. Block 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

In a recent article (1), Chapman et al described a genetic linkage of primary hip osteoarthritis (OA) with restricted areas on chromosome 11q. This is an elegant study, which may well provide important new insights into hip OA. Nonetheless, I would like to raise concerns about their choice of patien

Early response to immunosuppressive ther
✍ Frédéric A. Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) or a low‐dose IV CYC regimen (6 pulses of 500 mg g

Randomized controlled trial of standard
✍ W. H. Chan; L. W. Khin; Y. F. A. Chung; Y. C. Goh; H. S. Ong; W. K. Wong 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract ## Background Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate (pri